Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy

Abstract

This is the first long-term follow-up of patients who discontinued natalizumab. We did not observe a clinical, radiographic, or immunologic rebound phenomenon after discontinuation of natalizumab therapy.